Author:
Leung Felicia,Miljanic Simona,Fernandes Virginia,Tabbara Najla,De Castro Charmaine,Burry Lisa,Jorgensen Sarah CJ
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Obstetrics and Gynecology
Reference43 articles.
1. Adam MP, Polifka JE, Friedman JM (2011) Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet 157:175–182
2. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R (2004) Prescription drug use in pregnancy. Am J Obstet Gynecol 191:398–407
3. CADTH. 2016 ‘CADTH database search filters [Internet]. Ottawa.’
4. Canadian Pediatric Society (2021) Canadian pediatric society position statement. Selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors in pregnancy: infant and childhood outcomes. https://cps.ca/en/documents/position/selective-serotonin#:~:text=Conclusions,for%20both%20mother%20and%20newborn
5. Coates AO, Schaefer CA, Alexander JL (2004) Detection of postpartum depression and anxiety in a large health plan. J Behav Health Serv Res 31:117–133
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献